Trial Profile
Weekly cabazitaxel in elderly MCRPC (Metastatic Castration Resistant Prostate Cancer) patients progressing after docetaxel treatment: a phase II study.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 15 Mar 2018
Price :
$35
*
At a glance
- Drugs Cabazitaxel (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Acronyms WeCabE
- 10 Feb 2018 Results (n=14) presented at the 2018 Genitourinary Cancers Symposium.
- 10 Mar 2015 New trial record